Nova Pharmaceuticals has completely integrated R&D and manufacturing capabilities. Our manufacturing facilities are approved by TGA, US FDA, MHRA and similar regulatory authorities worldwide. Our research and development facility is TGA compliant and has ability to develop various dosage forms including tablets, soft gel capsules, liquids, caplets, powders etc.
With an in-house regulatory team with a combined 40 years’ experience in prescription, OTC and medical devices, Nova provides a well-rounded approach to the pharmaceutical industry.
Nova also has research and development partnerships with companies across the globe which help us to bring unique products to the Australian market, under Nova Pharma IP.